MedTrace Logo

Comparison of Three Different Myofascial Trigger Point Treatments in Chronic Non-Specific Neck Pain

NCT06814808 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2025-02-07

No results posted yet for this study

Summary

The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain \[SCS\]), and integrated neuromuscular inhibition technique (INIT) applications on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain.

It is planned to include 51 patients in the study. The included patients will be divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks.

Conditions

  • Chronic Non-specific Neck Pain

Interventions

OTHER

Conventional Therapy

All three groups will receive a conventional physiotherapy program (TENS, therapeutic ultrasound, hot pack) 5 times a week for 4 weeks and the same exercise program 3 days a week for 4 weeks.

OTHER

Ischemic Compression Group

The ischemic compression group will receive ischemic compression therapy for the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles.

OTHER

Strain-Counter Strain

The strain counterstrain technique will be applied to the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles.

OTHER

Integrated Neuromuscular Inhibition Technique (INIT)

This group will be subjected to INIT for the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles, 3 sessions per week for 4 weeks (12 sessions in total).

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Principal Investigators

  • Tansu Birinci Olgun, Asst prof. · Medeniyet University, Health Sciences Faculty Department

  • Maryam Zare, MD · Medical Park Gebze

  • Pınar Atamert, MSc · Biruni University, Health Sciences Faculty Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2025-12-15
Completion
2025-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06814808 on ClinicalTrials.gov